1 terminated, 1 withdrawn. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Terminated 1, Withdrawn 1 |
Follow Transplant-Related Hematologic Malignancy: new trials by email Literature Review of Transplant-Related Hematologic Malignancy trials Research Report on Transplant-Related Hematologic Malignancy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Treosulfan-TMI Conditioning and Rapamycin GvHD Prophylaxis Before Allo-HSCT Conditioning treatment "Treosulfan-TMI", SCT, GvHD prophylaxis - Irradiated Bone Marrow, Transplant-Related Hematologic Malignancy | Phase 1 | Terminated | IRCCS San Raffaele | 9 | 2014-02-12 | 2020-10-19 |
| Transplantation of Hematopoietic Progenitors From Haploidentical Donor With Selective in Vitro Depletion Allo-reactive Lymphocytes in Patient With High Risk Hematological Malignancies Allo-depleted lymphocyte infusion, Haploidentical transplantation of hematopoietic progenitors - Transplant-Related Hematologic Malignancy | Phase 1 | Withdrawn | Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud | 2013-01-01 | 2018-07-06 |
Graft vs Host Disease (1) · Leukemia (1) · Multiple Myeloma (1)
Blood Protein Disorders (1) · Cardiovascular Diseases (1) · Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1) · Hemorrhagic Disorders (1) · Hemostatic Disorders (1) · Immune System Diseases (1) · Immunoproliferative Disorders (1) · Lymphoproliferative Disorders (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms, Plasma Cell (1) · Paraproteinemias (1) · Vascular Diseases (1)
Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud (1) · IRCCS San Raffaele (1)
Italy (1) · Spain (1)